Загрузка...
Dendrogenin A Enhances Anti-Leukemic Effect of Anthracycline in Acute Myeloid Leukemia
SIMPLE SUMMARY: Recently, several molecules have improved the clinical outcome of acute myeloid leukemia (AML) patients. Despite these recent advances, their prognosis remains poor and new strategies to improve the standard anthracycline and Ara-C-based chemotherapy are needed. We recently published...
Сохранить в:
| Опубликовано в: : | Cancers (Basel) |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7601603/ https://ncbi.nlm.nih.gov/pubmed/33053669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102933 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|